Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, offering promising advancements across many professional medical and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, additional reliable option for therapeutic use,